An official website of the United States government
Coronavirus Disease – 2019 (COVID-19) Reports
Hospital COVID-19 Data Reports: these reports are either based on data collected from NHSN’s Hospital COVID-19 Module between April – July 2020, or provide an assessment of the impact of COVID-19 on HAIs and/or other patient safety topics.
Long-term Care Facility COVID-19 Data Reports are based on data collected from NHSN’s LTCF COVID-19 Module.
Hospital COVID-19 Data
- Brief Report: Quarterly National HAI Incidence in 2022
Summarizes national HAI data from 2022 and comments on the comparison of these SIRs to those from a pre-pandemic (2019) time period. The paper highlights the shift in quarterly MRSA bacteremia SIRs that occurred throughout 2022. Read more about annual HAI data here. - COVID-19 Impact on HAIs in 2020 and 2021 [Web Page]
Presents a comparison between 2019 and 2021 national standardized infection ratios (SIRs) for CLABSI, CAUTI, VAE, SSI, MRSA bacteremia LabID, and CDI LabID from acute care hospitals. For most HAIs, national SIRs in 2021 remain significantly higher than SIRs from the pre-pandemic time period. Infect Control Hosp Epidemiol 2022.- Presents a comparison between 2019 and 2020 national and state quarterly standardized infection ratios (SIRs) for CLABSI, CAUTI, VAE, SSI, MRSA bacteremia LabID, and CDI LabID from acute care hospitals. Infect Control Hosp Epidemiol 2021.
- Supplemental Data:
- Figure 1: Changes in the 2020 national HAI SIRs compared to 2019 [PDF – 300 KB]
- Changes in the national device-associated HAI SIRs, by location type, 2020 vs. 2019 [XLS – 34 KB]
- Quarterly SIR comparisons for each HAI type, by state, 2020 vs. 2019 [XLS – 228 KB]
- U.S. Maps: The Impact of COVID-19 on HAI Incidence, by State [PDF – 400 KB]
Compares CLABSI pathogen distributions and select antimicrobial resistance between 2019 and 2020 from acute care hospitals. Also provides a summary of common CLABSI pathogens among COVID-19 ICU patients. Infect Control Hosp Epidemiol 2022.
Summarizes hospital capacities and shortages of healthcare personnel and supply among US hospitals during the early phase of the COVID-19 pandemic. Infect Control Hosp Epidemiol 2021.
Summarizes the impact of COVID-19 on ICU capacities in the US by comparing the number of ICU beds reported to NHSN daily, between April – July 2020, to the ICU bed sizes reported on the 2019 NHSN annual surveys. Infect Control Hosp Epidemiol. 2021; 1-12.
Details a descriptive analysis of central-line–associated bloodstream infections (CLABSIs) in acute-care hospitals to determine potential impact of COVID-19 on standardized infection ratio (SIR). Data reported to NHSN in Q2 2020 was compared to Q2 2019. Infection Control & Hospital Epidemiology, 2021; 1-4.
Describes development of time series estimates from data reported to NHSN from April 1 – July 14, 2020 to allow near–real-time daily national and state indicators of the COVID-19 pandemic.
Infect Control Hosp Epidemiol. 2021; 1-8.
Long-term Care Facility COVID-19 Data
- Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant – February 14 – March 27, 2022 [PDF – 180 KB]
Analysis of COVID-19 surveillance and vaccination data from approximately 15,000 skilled nursing facilities found that, compared with primary series vaccination only, an additional or booster dose provided greater protection against SARS-CoV-2 infection during Omicron variant predominance. MMWR Morb Mortal Wkly Rep 2022. - Nursing Home COVID-19 Data Dashboard
